New study tracks wegovy use in pregnancy to assess baby safety
NCT ID NCT05872022
First seen Jan 18, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This observational study follows 728 pregnant women who took Wegovy for weight management and compares their babies' health to those not exposed. Researchers will track birth defects and infant development through the first year of life. The goal is to understand if Wegovy poses any risks during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novo Nordisk Investigational Site
Princeton, New Jersey, 08540, United States
-
Novo Nordisk Investigational Site
Madrid, Spain
-
Novo Nordisk Investigational Site
London, United Kingdom
Conditions
Explore the condition pages connected to this study.